These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function. Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641 [TBL] [Abstract][Full Text] [Related]
10. Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Bielory L; Gascon P; Lawley TJ; Young NS; Frank MM Medicine (Baltimore); 1988 Jan; 67(1):40-57. PubMed ID: 3257288 [TBL] [Abstract][Full Text] [Related]
11. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy. Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399 [TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study. Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082 [TBL] [Abstract][Full Text] [Related]
14. Rapid serologic diagnosis of serum sickness from antithymocyte globulin therapy using enzyme immunoassay. Tatum AH; Bollinger RR; Sanfilippo F Transplantation; 1984 Dec; 38(6):582-6. PubMed ID: 6334386 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients. Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin. Bielory L; Yancey KB; Young NS; Frank MM; Lawley TJ J Am Acad Dermatol; 1985 Sep; 13(3):411-7. PubMed ID: 3877081 [TBL] [Abstract][Full Text] [Related]
17. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480 [TBL] [Abstract][Full Text] [Related]
18. Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience. Kim JM; Jang HR; Ko JS; Kwon CH; Kwak MS; Hur WS; Kim SJ; Kim GS; Joh JW; Lee SK; Oh HY Transplant Proc; 2012 Jan; 44(1):171-4. PubMed ID: 22310607 [TBL] [Abstract][Full Text] [Related]
19. Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation. Di Filippo S; Boissonnat P; Sassolas F; Robin J; Ninet J; Champsaur G; Bozio A Transplantation; 2003 Feb; 75(3):354-8. PubMed ID: 12589158 [TBL] [Abstract][Full Text] [Related]
20. [Side effects and strategy in treating pediatric patients with aplastic anemia with anti-thymocyte globulin]. Wu W; Shen HP; Zhao FY Zhonghua Er Ke Za Zhi; 2006 May; 44(5):383-4. PubMed ID: 16780721 [No Abstract] [Full Text] [Related] [Next] [New Search]